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Abstract
Background: Peanut allergy is one of the most common and severe food allergies, and processing is known to influence the
allergenicity of peanut proteins. We aimed to establish the effect of heating and glycation on the IgE-binding properties and
biological activity of 2S albumins (Ara h 2/6) from peanut.
Methodology/Principal Findings: Native Ara h 2/6 was purified from raw peanuts and heated in solution (15 min, 110uC) in
the presence or absence of glucose. Ara h 2 and 6 were also purified from roasted peanut. Using PBMC and sera from
peanut-allergic patients, the cellular proliferative potency and IgE reactivity (reverse EAST inhibition) and functionality
(basophil degranulation capacity) of allergens were assessed. Heating Ara h 2/6 at 110uC resulted in extensive denaturation,
hydrolysis and aggregation of the protein, whilst Ara h 2 and 6 isolated from roasted peanut retained its native
conformation. Allergen stimulation of PBMC induced proliferation and Th2 cytokine secretion which was unaffected by
thermal processing. Conversely, IgE reactivity and functionality of Ara h 2/6 was decreased by heating. Whilst heating-
glycation further reduced the IgE binding capacity of the proteins, it moderated their loss of histamine releasing capacity.
Ara h 2 and 6 purified from roasted peanut demonstrated the same IgE reactivity as unheated, native Ara h 2/6.
Conclusions/Significance: Although no effect of processing on T-cell reactivity was observed, heat induced denaturation
reduced the IgE reactivity and subsequent functionality of Ara h 2/6. Conversely, Ara h 2 and 6 purified from roasted peanut
retained the structure and IgE reactivity/functionality of the native protein which may explain the allergenic potency of this
protein. Through detailed molecular study and allergenicity assessment approaches, this work then gives new insights into
the effect of thermal processing on structure/allergenicity of peanut proteins.
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Introduction
Peanut allergy is relatively common in the USA and certain
European countries with the prevalence of sensitization being
estimated as 2% and clinical peanut allergy as 1.2% of 3–4 years old
children in the UK [1]. Whilst the incidence appears to be
stabilising in the UK [1], it is still rising in the USA [2]. The peanut
2S albumins Ara h 2 and Ara h 6 together with a third low
abundance 2S albumin, Ara h 7 have been identified as major
peanut allergens [3,4,5]. Ara h 2 and 6 comprise several isoforms of
Mr 17 kDa and 15 kDa, respectively [6,7,8]. Produced as a single
chain precursor they are proteolytically processed in peanut seeds
into two subunits linked by intramolecular disulphide bonds [6,9].
Ara h 2, 6 and 7 are all members of the prolamin superfamily and
share a characteristic cysteine skeleton with at least 8 conserved
cysteine residues [9] and a three-dimensional structure comprising 5
a-helices arranged in a right-handed super helix. It appears this
scaffold is stable to thermal processing and proteolysis [7,10,11].
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Thermal processing of proteins can lead to alterations in their
structure that can result in changes in their immunoreactivity/
allergenicity. Typically, loss of tertiary structure is followed by
reversible unfolding, while loss of secondary structure (70–80uC)
leads to the formation of new intra/intermolecular interactions,
rearrangements of disulfide bonds (80–90uC), and formation of
aggregates (90–100uC) [12]. Heating in the presence of sugars
found in the foods also leads to modification by the Maillard
reaction (non-enzymatic browning). Free primary amino groups
are attacked by carbonyl compounds during the Maillard reaction,
leading to the formation of stable advanced glycation end products
(AGE). Several studies have been performed to assess the IgE-
binding capacity of purified allergens modified in vitro by heating
and/or by Maillard reactions. In some cases, glycation of allergens
enhanced their IgE binding capacity [13] or their T-cell
immunogenicity [14,15] whereas in other studies, glycation had
no effect or caused even decreased IgE-binding capacity [16,17].
Heating for 90 min at 100uC of recombinant refolded Ara h 2 led
to a slight increase in its IgE binding capacity, which was further
enhanced in the presence of glucose, maltose or ribose [18].
Heating native Ara h 2 for several days at 55uC in the presence of
different sugars increased its IgE binding capacity compared to
protein heated without sugar, which was related to the formation
of AGE products [19]. Ara h 2 extracted from heat-processed
peanut, such as roasting (140uC) was also found to enhance its IgE-
binding capacity [20].
Although IgE binding capacities of modified allergens have
been studied, sometimes with conflicting results, few data are
available on the impact of heating on the protein structure and on
the resultant biological activity of modified allergens compared to
unmodified ones. In order to give new insights into the effect of
thermal processing on structure/allergenicity of peanut proteins,
we then purified and produced well-characterized native, heated
and glycated Ara h 2/6, as well as corresponding protein from
roasted peanut. Using a large panel of sera and peripheral blood
mononuclear cells (PBMC) from well-characterized peanut-
allergic patients recruited in different European countries, we
then investigated the effect of thermal modifications on IgE
reactivity of Ara h 2/6, but also on its biological activity, i.e.
basophil activation, T-cell induced proliferation and cytokine
production capacities.
Results
Effect of thermal processing on Ara h2/6 structure
Native Ara h 2/6 (N-Ara h 2/6) gave a far-UV CD spectrum
typical of an a-helix rich protein (Figs 1A and 1B) consistent with
previous studies [21] and was monomeric with a Mr of ,16 kDa
(Fig. 1C) consistent with a mixed preparation of Ara h 2/6 [7].
After heating at 110uC for 5–10 min in the absence [H-Ara h 2/6,
Fig. 1A] or presence [G-Ara h 2/6, Fig. 1B] of glucose secondary
structure shifted toward an unordered state which dominated after
15 min heating, with a loss of both the maximum at 198 nm and
the minima at 209 and 222 nm. Heating in the presence or
absence of glucose also affected the aggregation state of the
protein, with only ,20% of the protein remaining in its
monomeric state (Fig. 1C). A broad peak eluting with a Mr
,28–30 kDa of aggregated protein, together with a smear of
material of Mr 44–150 kDa corresponding to larger oligomers was
observed. In addition, thermal treatment resulted in hydrolysis of
the Ara h 2/6 to yield fragments of smaller size than the parent
protein. Far-UV CD spectra obtained for Ara h 2 (data not shown)
and Ara h 6 (Figure 1D) purified from roasted peanut were
comparable and demonstrated the same a-helix rich protein
structure as N-Ara h 2/6. Non-denaturating electrophoresis
showed the proteins were mainly monomeric (data not shown).
In order to study the effect of heat-induced structural changes
on allergenicity of 2S albumins, N-Ara h 2/6 was then further
heated for 15 minutes at 110uC in the presence or absence of
glucose.
Effect of thermal processing on PBMC induced
proliferation and cytokine production capacity
No difference was observed between PBMC from PA or NA
patients regarding differentiation markers, viability and cytokine
secretion potency at the time of sampling and/or after polyclonal
activation using aCD3/aCD28 antibodies (data not shown). The
effect of thermal treatment on the capacity of Ara h 2/6 to
stimulate T-cell proliferation and cytokine production by PBMC
of peanut allergic patients was determined by culturing cells for 7
days in the presence or absence of native and thermally-modified
Ara h2/6. Stimulation with Ara h 2/6 did not induce significant
proliferation in the NA controls (Fig. 2A) and only three of the 12
PA subjects showed detectable numbers of Ki-67+ proliferating
cells (10.564.8%) in the Ara h 2/6 stimulated cultures compared
with medium alone (4.762.7). The CD4+CD25+ subset was the
largest cell population present in the corresponding proliferating
PBMC. Thermal treatment of N-Ara h 2/6 had no effect on its
capacity to induce PBMC proliferation in the three subjects
(Fig. 2B). PBMC cultures from NA subjects stimulated with the
native and modified Ara h 2/6 did not show any cytokine
induction for all five tested cytokines (Fig. 3 and data not shown).
Conversely, IL-5 and IL-13 production was significantly and
equally enhanced in PBMC cultures from 5 out of 12 PA subjects
following stimulation with N-, H- or G-Ara h 2/6 (Figs 3A and
3B). Enhanced production of IL-10 and IFN-c was observed in
stimulated PBMC of PA subjects compared to NA subjects but was
not significant for all stimuli tested (Figs 3C and 3D). IL-17
production was below 20 pg/ml for all tested conditions (data not
shown).
Effect of thermal processing on the IgE binding capacity
Screening of the serum panel (n = 34, Table 1) showed variable
levels of IgE specific to raw peanut extract and N-Ara h 2/6. Four
sera with low specific IgE were excluded from subsequent analysis
(sera#69,#76,#80 and#82). Effect of thermal treatment on the
IgE binding capacity of Ara h 2/6 was then assessed using reverse
inhibition. A typical inhibition curve for the reverse EAST assay
obtained with serum #05-0209 is shown in Figure 4A and
demonstrated that the thermal treatment of N-Ara h 2/6 at 110uC
reduced its IgE binding capacity. Ara h 2/6 from roasted peanut
(R-Ara h 2/6) had a similar albeit slightly reduced immunoreac-
tivity to N-Ara h 2/6 from raw peanut. IC50 values calculated for
the entire serum panel (n = 30) are consistent with this and show
that extreme thermal processing did reduce the IgE binding
capacity of Ara h 2/6 in a significant manner (Fig. 4B). The IC50
values for all tested sera increased 1.2 to 44-fold (mean = 9.6,
n = 30) for H-Ara h 2/6 compared to N-Ara h 2/6 (Fig. 4 B). For
25 out the 30 tested patients, IC50 values for G-Ara h 2/6 were
equivalent or 3.4-fold higher than those of H-Ara h 2/6 (mean =
1.7). For the last 5 patients, sampled in various countries, IC50
values were 1.2 to 1.7-fold lower for G-Ara h 2/6 compared to H-
Ara h 2/6 (mean 1.4). These data show that for most patients
glycation reduced the IgE reactivity of Ara h 2/6 still further
compared with thermal treatment alone, and is consistent with the
fact that IC50 values for G-Ara h 2/6 were 1.3 to 73-fold higher
than that of N-Ara h 2/6 (mean = 14.5, n= 30). Ara h 2/6 from
Allergenicity of Heat-Modified Ara h 2/6
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roasted peanut (R-Ara h 2/6) had a similar albeit slightly reduced
immunoreactivity to N-Ara h 2/6.
Effect of thermal processing on the mediator-releasing
capacity
Subsequently an analysis of the effects of heating on the
histamine releasing capacity of the Ara h 2/6 preparations was
undertaken using human stripped basophils passively sensitized
with 23 of the 34 peanut-allergic patients sera and compared with
whole protein extract from raw or roasted peanut. No histamine
release was induced by the different allergens when using a serum
from patients not sensitized to peanut (data not shown), and the 23
sera from PA patients gave similar results. An example curve
(serum #2305, Fig. 5A) shows significant histamine release for
both extracts and purified allergens, the whole protein extract
from raw and roasted peanut being comparable. As previously
observed using RBL SX38 cells and Ara h 2 and Ara h 6 from
roasted peanut [22], histamine release was induced at lower
concentrations of these purified allergens when compared to
peanut extracts. Heating reduced the biological potency of the Ara
h 2/6, (Fig. 5A, P,0.05 when considering 23 sera), but
intriguingly histamine release was induced at a lower concentra-
tion of heated-glycated than heated Ara h 2/6. The maximum
histamine release induced by the purified allergens was only
affected when comparing N-Ara h 2/6 to H-Ara h 2/6 (P,0.05
when considering the 23 sera).
Additionally, a mediator release assay using humanized Rat
Basophilic Leukaemia cells was also performed using 6 individual
sera. Figure 5B shows typical results of a representative serum
(#70) and the inserted table represents the average protein
concentrations needed to obtain 50% of the maximum mediator
release induced by the native allergen (EC50). A 150 and 130
times increased EC50 value, corresponding to a decreased
allergenic activity, was observed for H-Ara h 2/6 and G-Ara h
2/6, respectively, in comparison to N-Ara h 2/6. The EC50 value
of G-Ara h 2/6 was lower compared to the EC50 value of H-Ara h
2/6; however, this was not tested to be significantly different.
Discussion
Boiled peanuts are consumed in many countries, from China to the
Southern states of the USA. Boiling is performed for 2 to 7 hours,
depending on the peanut source, and boiled peanut can be further
canned, then involving further extensive heating (45 minutes at 120uC
under 10 pounds pressure per square inch). Study of heat-induced
structural changes and its impact on allergenicity of peanut allergens
Figure 1. Effect of heating on secondary structure and oligomeric state of Ara h 2/6. Far-UV CD spectra of Ara h 2/6 heated alone (A, H-Ara
h 2/6) or in the presence of 100 mM glucose (B, G-Ara h 2/6) before heating (N-Ara h 2/6, —) and for heated-cooled protein after heating to 110uC for
15 min (222) and 60 min (---). Inset graphs show change in molar residue ellipticity at 228 nm with heating time. Size exclusion chromatography
profiles (C) are shown of the Ara h 2/6 before and after heating for 15 min at 110uC in the presence or absence of glucose. Retention volumes of
molecular weight standards (size indicated in kDa) are shown by arrow heads. D. Far-UV CD spectra of Ara h 6 purified from roasted peanut.
doi:10.1371/journal.pone.0023998.g001
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Figure 2. Effect of thermal treatment on subpopulation of proliferating cells. A. Fresh PBMC were left unstimulated (Med) or stimulated
with N-Ara h 2/6 for 7 days. After harvesting, the cells were incubated with anti-CD4/CD25 antibody and afterwards stained for an anti-Ki-67 PE
antibody. Data are mean percentage of Ki-67 positive cells 6 SEM values for three (#65, #66 and #70) of the 12 PA subjects and seven NA controls.
The percentage Ki-67+ cells was divided in the following subpopulations of cells: CD4-CD25- (dark grey bars), CD4+CD25- (white bars), CD4-CD25+
(black bars) and CD4+CD25+ (light grey) cells. B. Fresh PBMC were left unstimulated (Med) or stimulated with N-, H- or G-Ara h 2/6 for 7 days. Data
are mean percentage of Ki-67 positive cells 6 SEM values for three peanut-allergic patients (#65, #66 and #70) (white bars) and seven non-allergic
controls (grey bars).
doi:10.1371/journal.pone.0023998.g002
Figure 3. Effect of thermal treatment on cytokine induction capacity. Fresh PBMC were left unstimulated (Med) or stimulated with N-, H- or
G-Ara h 2/6 and production of IL-5 (A), IL-13 (B), IL-10 (C) and IFN-c (D) was measured after 7 days of culture. Symbols represent peanut-allergic
patients #65 (&), #66 (¤), #70 (m), #67 (N) and #73 (6). Horizontal bars represent the mean of the five PA responder subjects (solid) and the mean
of 7 NA controls (dotted). Asterisks indicate statistically significant differences between the PA and the NA group and # indicate statistically
significant differences between the medium and allergen-stimulated cultures for the PA group (*, #: P,0.05). No differences between the medium
and allergen-stimulated cultures were observed for the NA group.
doi:10.1371/journal.pone.0023998.g003
Allergenicity of Heat-Modified Ara h 2/6
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after wet-thermal processing then appears of interest. Achievingmodel
processing conditions to ensure that thermal modifications can be
monitored by structural and immunological analysis is difficult since
heating frequently renders much of the protein insoluble. This makes
purification of proteins from cooked foods, such as roasted or boiled
peanuts, cumbersome [23]. We then analyzed the effect of wet
thermal processing on major peanut allergens, i.e. N-Ara h 2/6,
previously purified from raw peanut. Like other members of the
prolamin superfamily, the 2S albumin allergens of peanut appeared to
be highly thermostable. The present detailed molecular study shows
that these proteins only begin to unfold following heating at
temperatures over 100uC, conditions which equate to boiling for
extended times (longer than 15 min). After this time the protein adopts
a random coil conformation and forms dimers and higher order
oligomers, accompanied by hydrolysis of the peptide backbone. Such
effects of thermal denaturation have been observed for other food
Table 1. Serological and clinical information for the 34 peanut allergic patients recruited in different European centres, within the
Europrevall European project, used in EAST studies, basophil histamine release tests and/or PBMC proliferation tests.
Code
Gender
(f/m) Age
Peanut SPT
(HEP index
numbers)
Grade
peanut
allergy
Peanut
RAST
class
peanut
CAP
(IU/ml)
Anti-whole
peanut
IgE (IU/ml)
Anti-Ara h
2/6 IgE
(IU/ml)
Other
food
allergies
2A m 31 positive 3/4 5 51.7 43 31
52A m 41 nd 4 5 nd 166 62
54A f 11 2.2 1 6 .100 72 57
55A f 14 3.3 4 6 .100 363 137
56A m 16 1.5 2 6 .100 79 56
58A f 22 2.5 4 6 .100 171 110 Soy, lupine, pea
65 f 19 positive 3/4 6 .100 587 208
66 m 18 positive 4 6 .100 290 71
67 f 46 nd 3 5 54.4 95 35 Hazelnut, kiwi, cherries
68 f 20 positive 1 4 17.6 16 6
69 m 21 positive 3/4 3 6.98 3.5 1.2
70 f 21 positive 3/4 6 .100 224 76 Soy, pea, apple
73 f 22 positive 2/3 4 33.6 21 3.7 Hazelnut
76 m 23 positive 3 3 8.6 4.2 0.3
77 m 25 positive 2 4 33.2 22 3.5
78 f 24 positive 3 5 79.6 65 29 Hazelnut
80 m 27 positive 3 3 16 12 17
82 f 18 positive 1/2 3 4.7 25 6.4 Kiwi, cherries
1682 m 33 nd 4 6 .100 13 10
1691 m 22 nd 3 5 nd 50 54
2207 m 28 nd 4 4 nd 38 26 Wheat, hazelnut, egg, almond
2209 f 27 nd 4 6 nd 75 51 Hazelnut, egg, wheat
2304 m 25 nd 3 6 nd 90 50
2305 f 18 nd 4 nd nd 52 36
03–0043 f 20 1,54 3/4 6 .100 nd 852 Hazelnut, walnut, melon
03–0044 m 23 4,33 3 6 .100 nd 231 Egg, fish, shrimp, hazelnut,
walnut, sesame, wheat,
sunflower
03–0079 f 16 2,22 3 6 .100 nd 88 Pistachio, almond, brazil nut
05–0128 f 25 1,92 3 6 .100 nd 358 Soy, hazelnut, apple, peach
05–0165 f 18 0 3/4 6 .100 nd 429 Chickpea, bean, hazelnut, lentil
05–0195 m 31 2,13 3 5 63,5 nd 64 Soy
05–0209 m 20 99,98 4 5 70,2 nd 81 Pea, soy, bean
06–0010 m 19 2,2 3/4 5 67,4 nd 67 Fish
08–0069 m 17 2,08 1 6 .100 nd 139 Kiwi
12–0048 f 21 5,8 3/4 5 54,6 nd 88 Shrimp
HEP: histamine equivalent prick test; nd: not determined. Where known, other allergies of the subjects are indicated.
The origin of the sera is as follows: 2A: Zurich, 52A: Amsterdam, 54A-82: Arnhem, 1682-2305: Vienna; 03-0043 till 12-0048 EuroPrevall Serum Bank.
Grading is based on Brockow and Ring and on Sampson et al. [41,42]. Grade 1 =dermal symptoms; grade 2 = gastro-intestinal problems like nausea and or cramping;
grade 3 = any of the former grades plus vomiting/diarrhoea and respiratory tract problems like throat pruritis or tightness, grade 4 = any of the former grades and
respiratory arrest plus cardiovascular problems like hypotension.
doi:10.1371/journal.pone.0023998.t001
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proteins, including the lipid transfer protein from barley which shares
the same protein scaffold as the 2S albumins [24]. Interestingly, the
Ara h 2 and 6 purified from roasted peanuts had retained the
structural characteristics of the native protein purified from raw
peanuts, as indicated by far-UV CD spectra and non-denaturing
electrophoresis. In addition, proteins from roasted peanut have a
similar IgE immunoreactivity as the unheated protein. These data
thus demonstrate that the proportion of the protein in roasted peanut
that was still soluble and then extractable had not been denatured by
the roasting process, probably due to protection within the peanut
seed.
In order to assess the effect of heat-induced structural changes on
allergenicity of Ara h 2/6, the in vitro proliferation and cytokine
production capacity of the native vs heated proteins were tested
using PBMC from 12 peanut allergic (PA) and 12 control human
donors. Out of the 12 PA, only 3 demonstrated significant
proliferation, as assessed by Ki-67 labeling, and 5 demonstrated a
significant cytokine production after in vitro stimulation. All of them
had high levels of peanut specific IgE antibodies. This corroborates
studies demonstrating a significant positive correlation between
allergen-specific serum IgE levels and high numbers of IL-4-
producing cells [25] or active proliferation of T cells and Th2
cytokine production [26]. However, it is worth noting that peanut-
specific T-helper cells in PBMC of peanut allergic patients were
found to be only 0.6% of the total CD4+ T cells [27], thus
explaining the quite low rate of responders in our ex vivo stimulation
Figure 4. Effect of thermal treatment on the IgE binding
capacity of Ara h 2/6. A. IgE capture inhibition curves obtained for
sera #05-0209 with N-Ara h 2/6 (N), H-Ara h 2/6 (X) or G-Ara h 2/6 (m).
IgE binding capacities of native and heated processed Ara h 2/6 was
assessed by competitive assays in the IgE capture format. Inhibition was
performed into microtiter plates coated with anti-IgE, and previously
incubated with allergic patient sera at convenient dilution. Competition
was then conducted by adding increasing concentrations of compet-
itors at the same time as biotinylated N-Ara h 2/6. Competition
obtained with Ara h 2/6 purified from roasted peanut is shown as a
clear circle. B. Analysis of IC50 (ng/ml) values obtained using an IgE
capture inhibition assay with native and heat processed Ara h 2/6 as
competitors using 30 individual sera from peanut-allergic patients.
Increase in IC50 value corresponds to a decrease in IgE-binding
capacity. R-Ara h 2/6: mix of Ara h 2 and Ara h 6 purified from roasted
peanut. Bars indicate a significant difference between the 2 corre-
sponding treatments (P,0.05, non-parametric Wilcoxon signed rank
test).
doi:10.1371/journal.pone.0023998.g004
Figure 5. Effect of thermal treatment on the activation of
effector cells induced by Ara h 2/6. (A) Human stripped basophils
were passively sensitized with individual sera (#2305) and then
incubated with increasing concentrations of N-Ara h 2/6 (N), H-Ara h
2/6 (X), and G-Ara h 2/6 (m), or whole peanut extract from raw (w) or
roasted (#) peanut. Histamine release was assayed in corresponding
supernatants. Twenty-three sera out of the 35 available corresponding
to all sera from Zurich, Amsterdam, Vienna and EPSB, and sera 54A to
58A from Arnhem were used, giving similar results (not shown). No
histamine release was induced by the different allergens when using a
serum from patients not sensitized to peanut (data not shown). (B)
Humanized RBL-2H3 cells were passively sensitized with sera from
peanut-allergic patients (#70) and stimulated with increasing concen-
trations of native (N; _N_), heated (H; – –X– –) or glycated (G; - - -m- - -)
Ara h 2/6. Error bars represent the SD of triplicate values. No b-
hexosaminidase release was induced by the different allergens when
using sera from non-allergic patients (data not shown). The table
presented within the figure represents the average protein concentra-
tions (ng/ml, n = 6) to obtain 50% of the maximum allergen release of
the native allergen (EC50). Means without a common letter differ
(P,0.05).
doi:10.1371/journal.pone.0023998.g005
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assays. However this does not preclude that heat treatment of Ara h
2/6 did not influence cytokine production by PBMC from all of the
5 PA responders, regardless of the presence of glucose. Interestingly,
internalization of glycated ovalbumin was recently studied in
human dendritic cells and an increased uptake of glycated
ovalbumin compared to the native protein was observed, which
finally led to increased CD4+ T-cell immunogenicity of this protein
[14,15]. However, in our study, monocytes are the primary antigen-
presenting cell population, T cells are already primed by the
proteins, and the used model allergens are different, which renders
comparison difficult. Our results demonstrated that the hydrolysis,
unfolding and aggregation of the Ara h 2/6 by intense heating,
regardless of the presence of glucose, had no effect on stimulating
the activity of PBMCs from PA-patients, as has been shown before
for Bet v 1-related allergens [28,29]. This demonstrated that T-cell
epitopes were still present in the modified proteins.
The IgE-binding capacity and the elicitation potency of the native vs
heat-processed allergens were then studied using a large panel of sera
from peanut allergic patients (n=30 and 23, respectively). In fact, most
of the studies aiming at analyzing the relationship between structure
and allergenicity, and particularly the effect of processing on
allergenicity of food proteins, generally use very few individual sera
from allergic patients [18,23,30,31], even sometimes only one pool of
such sera is available [11,19,32,33]. In the present study, a large
population of peanut allergic patients from various European countries
was involved leading to significant conclusions. Many studies have
demonstrated that physicochemical modifications of proteins, e.g.
resulting from processing, may impact on their IgE binding capacity.
This includes denaturation or hydrolysis which may lead to the
destruction of conformational epitopes, and thus to a decreased IgE
binding capacity. Inversely, structural modifications may result in the
unmasking of epitopes hidden in the tertiary structure of the molecule
and that thus become available for IgE binding. The European Food
Safety Authority opinion relating to the evaluation of allergenic foods
for labelling purposes also acknowledged that the data available do not
indicate whether and how food processing predictably influences
allergenicity [34,35]. With regards to peanut 2S albumins, several
linear epitopes have been identified for Ara h 2 [36,37,38,39] and some
of them have been proposed as a marker of persistent peanut allergy
[38]. However, the relative binding of IgE to the corresponding
peptides versus to the native protein was not analyzed. Interestingly,
Bernard and coworkers showed that the IgE binding capacity of Ara h
6 was decreased for all the peanut allergic patients in their study and
even abolished for 25% of them when the molecule was denatured by
reduction and carboxymethylation. This demonstrates the importance
of conformation in the allergenicity of this protein and the presence of
both conformational and linear epitopes, at least for 75% of their
population [6]. In the present study, heat-induced denaturation,
hydrolysis and aggregation of Ara h 2/6 result in a significant loss in
IgE-binding capacity and ability of the protein to elicit histamine
release for all tested sera. Altogether, these results suggest that IgE
responses in peanut-allergic individuals are mainly directed towards the
natively folded protein. Hydrolysis and oligomerisation observed after
heating with or without glucose, may have led to further linear epitope
degradation and masking. Thus, it appears that the sensitizing agent
driving B-cell responses in this population was mainly native Ara h 2/6
which may have originated from either consumption of raw nuts, or
more probably, represent the fraction of Ara h 2/6 that remains soluble
and in its native state even after roasting. However, this also indicates
that thermal processing can reduce the allergenic activity of peanut
proteins, andmay explain why processes such as boiling of peanuts, can
reduce their allergenic activity [32].
This study showed that glycation in conjunction with thermal
denaturation generally led to a further decrease of IgE binding
capacity, rather than the increase found by others [18,40],
although glycation did appear to preserve slightly more of the
proteins mediator releasing capacity compared with heating alone.
Some of these differences may relate to the wet-thermal processing
procedures employed in this study. Further investigation using
heat-denaturation of Ara h 2/6 under low moisture conditions will
be required to explain these differences more fully.
In conclusion, heating to temperatures able to denature Ara h
2/6 caused a significant decrease in the proteins allergenicity
whereas T cell stimulation was not affected which can render these
modified proteins attractive for immunotherapy. It is evident that
a soluble fraction of the Ara h 2/6 from roasted peanuts retains the
conformation and allergenic activity of the native protein,
explaining the allergenic potency of this protein.
Materials and Methods
Ethics statement
A written informed consent was obtained before the sample
collection (serum or serum and PBMC) and the performed
experiments were approved by the corresponding local ethical
committees (Kantonale Ethikkommission Zu¨rich, Medical ethical
committee of the Amsterdam Medical Centre, Ethics Committee
of Medical University of Vienna, Commissie Mensgebonden
Onderzoek regio Arnhem-Nijmegen).
Patient characteristics
Thirty-four peanut-allergic (PA) patients (17 males and 17
females, mean age: 23 years) were recruited in Zurich,
Amsterdam, Vienna and Arnhem, or were provided by the
Europrevall Serum Bank (EPSB) (table 1). Peanut allergy was
established using clinical history, physical examination, peanut
specific IgE (ImmunoCAP and/or RAST (Phadia AB)) and/or
objective clinical manifestations observed after peanut ingestion.
Grading of food-induced anaphylaxis was according to severity of
clinical symptoms [41,42]. Twelve PA subjects and 12 non-allergic
(NA) controls, all recruited from the Allergology Practice Arnhem
(APA, The Netherlands), donated cells for PBMC cultures.
Peanut 2S albumins (Ara h 2/6) preparations
Native 2S albumins containing both Ara h 2 and Ara h 6 (N-
Ara h 2/6) were purified from unroasted redskin type peanut as
described previously [21] and stored at 220uC prior to use. This
purification involves ammonium sulphate fractionation and gel-
filtration chromatography, avoiding the use of denaturing
conditions such as reverse phase HPLC. Allergen identity was
confirmed by in gel-trypsin digestion and MALDI mass spec-
trometry. Ara h 2 and Ara h 6 were purified from commercial
roasted peanut as previously described [20] which involves anion
exchange chromatography in 4 M urea followed by reverse phase
HPLC, and then mixed (62% Ara h 2 and 38% Ara h 6) in
proportions representative of proportions found in peanut [43] to
provide a preparation further referred to as R-Ara h 2/6.
Proteins were standardized according to BCA kit from Pierce,
following provider recommendations.
Heating and glycation treatments of peanut 2S albumins
(Ara h 2/6)
Native Ara h 2/6 (N-Ara h 2/6, 4 mg/ml) in 32.5 mM phosphate
buffer containing 100 mM NaCl, was heated for 15 min to 110uC
alone (H-Ara h 2/6) or in the presence of 100 mMglucose (G-Ara h 2/
6). Heating in the presence of glucose was undertaken to glycate the
protein based on a previously used protocol [44]. Protein solutions
were allowed to cool to room temperature prior to analysis.
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Biochemical characterization of native and modified Ara
h 2/6
Changes in Ara h 2/6 secondary structure were assessed using
far-UV (190–260 nm) circular dichroism (CD) spectroscopy using
either a J-710 or a JASCO-810 spectropolarimeter (Jasco Ltd.,
Japan) as previously described [7,21]. All data were calculated in
terms of molar ellipticity. Aggregation state was monitored using
size exclusion chromatography on a Superdex-75 column attached
to an A¨kta Basic FPLC (Amersham Biosciences, Little Chalfont,
UK) [21], and calibrated with a set of gel filtration molecular
weight standards (BioRad, Hertfordshire, UK).
Isolation, culture and stimulation of human peripheral
blood mononuclear cells
PBMC were isolated and cultured as previously described [45].
Immunological phenotyping of freshly isolated PBMC was
performed on a FACS Canto II (BD Pharmingen, San Diego,
USA), using monoclonal antibodies and the procedure from BD
Pharmingen (San Diego, USA). Stimuli were incubated for at least
30 min with polymyxin B (50 mg/ml, Sigma, Zwijndrecht, The
Netherlands) to remove potential endotoxin activity prior to
addition of the stimuli to the PBMC. PBMC were stimulated with
aCD3/aCD28 (150 ng/ml aCD3, 100 ng/ml aCD28) or N-, H-
or G-Ara h 2/6 (20 mg/ml) and supernatants harvested after 4 and
7 days of culture and stored at 280uC. The 20 mg/ml dose was
determined as optimal in preliminary studies using doses ranging
from 5 to 40 mg/ml (data not shown). The specificity of the
proliferative and cytokine production capacities were assessed in a
pilot study using PBMC from 5 peanut allergic patients with 2
control proteins (ovalbumin and purified 7S globulin from soy (Gly
m 5), 20 mg/ml). No differences between the medium control and
the control proteins with respect to cytokine induction and
proliferation were observed. Early apoptosis and late apoptosis/
necrosis was assessed on freshly prepared and 7 day cultured cells
using double staining with APC-Annexin V and propidium iodide
(PI) [46]. PBMC proliferation was studied on day 4 and day 7 by
analysis of intracellular expression of the nuclear Ki-67 antigen
(BD Pharmingen, San Diego, USA) [46] of PBMC previously
stained with anti-CD4/CD25 antibody. Ki-67 expression by
CD4+ and CD25+ cells was then determined by flow cytometry.
Cytokine analysis
Cytokine production by PBMC was analysed in supernatants of
cells cultured for 4 and 7 days. The production of IL-5, IL-10, IL-13,
IFN-c and IL-17 by PBMC cultures was determined in harvested
supernatants using Cytometric Bead Array (CBA, BD Biosciences,
San Diego, CA) on a FACSCanto II cytometer and the procedure was
performed according to the manufacturer’s protocol. Preliminary
experiments demonstrated low specific induction of IL-4 that
correlated to higher specific induction of IL-5 and IL-13, all indicative
of Th2 cellular responses. Therefore, IL-4 was not determined in the
full experiments using PBMC from 12 NA and 12 PA donors. The
detection limit was 1.1 pg/ml for IL-5, 0.13 pg/ml for IL-10, 0.6 pg/
ml for IL-13, 1.8 pg/ml for IFN-c and 0.3 pg/ml for IL-17.
IgE immunoreactivity
Concentrations of IgE specific to whole protein extract from
raw peanut and to N-Ara h 2/6 were determined using enzyme
allergosorbent tests (EAST) as previously described [3,20].
Reverse EAST inhibition was performed as described elsewhere
[47] using anti-human IgE (mouse monoclonal, clone LE27) as a
capture antibody, biotinylated N-Ara h 2/6 (200 ng/ml) as tracer
and N-, H-, G- or R-Ara h 2/6 as inhibitors. N-Ara h 2/6 was
labelled with biotin using EZ-link sulfo-NHS-LC biotin (Pierce,
Rockford, IL). Assays were developed using streptavidin labelled
with acetylcholine esterase (AChE) and Ellman’s reagent. The
absorbance of each well was measured at 414 nm and results
expressed as B/B0, where B0 and B represent the amount of native
Ara h 2/6 tracer bound to captured IgE in the absence or presence
of a known concentration of inhibitor, respectively.
Effector cells activation by natural and modified allergens
Basophil histamine release (BHR) tests were performed as
described in [49] using stripped basophils from fresh buffy coats
(Blood Bank, National University Hospital of Copenhagen,
Denmark) and reagents from RefLab (Copenhagen, Denmark).
Twenty-three sera out of the 34 available were used individually in
the BHR test, corresponding to all sera from Zurich, Amsterdam,
Vienna and EPSB, and sera 54A to 58A from Wageningen.
RBL-2H3 cells expressing the a-chain of the human FceRI
receptor [49] were kindly provided by Drs. Vieths and Vogel
(Paul-Ehrlich-Institut, Langen, Germany). RBL cells were cultured
in MEM medium supplemented with 5% fetal calf serum and 1%
glutamine (all from Gibco-BRL, Paisley, UK) at 37uC in a
humidified atmosphere with 5% CO2. Cells in stationary growth
phase were harvested and plated in 96-well plates at 1.56105 cell/
well. Six sera from PA patients (#65, #66, #67, #70, #55A and
#56A) at pre-determined convenient dilutions and two sera from
non-allergic patients were added and incubated overnight to
passively sensitize the cells. After washing, the cells were stimulated
for 1 h with the allergens diluted in Tyrode’s buffer containing
50% deuterium oxide [49]. The antigen-specific release was
quantified by measuring b-hexosaminidase activity and expressed
as percentage of the total b-hexosaminidase content that was
obtained by lysing the cells with Triton-X100 (Sigma-Aldrich,
Zwijndrecht, The Netherlands). The release data were fitted to
four-parameter-logistic curves by non-linear regression using the
SigmaPlot 10.0 software package, and EC50 values were
calculated accordingly.
Statistical analysis
Statistical analysis was performed by using SPSS (v18.0, SPSS
Inc., Chicago, USA) or GraphPad Prism v4.00 for Windows
(GraphPad Software, San Diego, CA). Means and medians were
analysed using Wilcoxon signed rank test for specific IgE levels and
PBMC cytokine production and the Mann-Witney U test for
comparing PBMC cytokine production between PA and the
control patient groups. Differences were interpreted as significant
when P,0.05.
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